Comparison of p40 (ΔNp63) and p63 expression in prostate tissues - which one is the superior diagnostic marker for basal cells?

The use of immunohistochemistry for diagnosis of prostate cancer

(2017) Katia R. M. Leite et al.   International Braz J Urol

A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas

(2012) Daisuke Nonaka   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemical pitfalls in prostate pathology

(2012) Fadi Brimo et al.   HUMAN PATHOLOGY

The Androgen-Regulated Calcium-Activated Nucleotidase 1 (CANT1) Is Commonly Overexpressed in Prostate Cancer and Is Tumor-Biologically Relevant in Vitro

(2011) Josefine Gerhardt et al.   AMERICAN JOURNAL OF PATHOLOGY

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

(2011) Justin A Bishop et al.   MODERN PATHOLOGY

p63in Epithelial Survival, Germ Cell Surveillance, and Neoplasia

(2010) Christopher P. Crum et al.   Annual Review of Pathology-Mechanisms of Disease

Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials

(2010) Naoto Kuroda et al.   Medical Molecular Morphology

Usefulness of Cytokeratin 5/6 and AMACR Applied as Double Sequential Immunostains for Diagnostic Assessment of Problematic Prostate Specimens

(2009) Kiril Trpkov et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Aberrant Diffuse Expression of p63 in Adenocarcinoma of the Prostate on Needle Biopsy and Radical Prostatectomy: Report of 21 Cases

(2009) Adeboye O. Osunkoya et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Aberrant Cytoplasmic Expression of p63 and Prostate Cancer Mortality

(2009) P. K. Dhillon et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

(2008) G Kristiansen et al.   BRITISH JOURNAL OF CANCER